191 related articles for article (PubMed ID: 19623013)
1. Insufficient Antigen Presentation Due to Viral Immune Evasion Explains Lethal Cytomegalovirus Organ Disease After Allogeneic Hematopoietic Cell Transplantation.
Holtappels R; Schader SI; Oettel O; Podlech J; Seckert CK; Reddehase MJ; Lemmermann NAW
Front Cell Infect Microbiol; 2020; 10():157. PubMed ID: 32351904
[TBL] [Abstract][Full Text] [Related]
2. GVHD prophylaxis: use an ortho IL-2/IL-2Rβ Treg system!
Wolf D
Blood; 2023 Mar; 141(11):1246-1247. PubMed ID: 36929438
[No Abstract] [Full Text] [Related]
3. Transplantation tolerance: Clinical potential of regulatory T cells.
Muller YD; Seebach JD; Bühler LH; Pascual M; Golshayan D
Self Nonself; 2011 Jan; 2(1):26-34. PubMed ID: 21776332
[TBL] [Abstract][Full Text] [Related]
4. T cells engrafted with a UniCAR 28/z outperform UniCAR BB/z-transduced T cells in the face of regulatory T cell-mediated immunosuppression.
Kegler A; Koristka S; Bergmann R; Berndt N; Arndt C; Feldmann A; Hoffmann A; Bornhäuser M; Schmitz M; Bachmann MP
Oncoimmunology; 2019; 8(9):e1621676. PubMed ID: 31428518
[TBL] [Abstract][Full Text] [Related]
5. Unraveling the Mechanisms of Cutaneous Graft-Versus-Host Disease.
Santos E Sousa P; Bennett CL; Chakraverty R
Front Immunol; 2018; 9():963. PubMed ID: 29770141
[TBL] [Abstract][Full Text] [Related]
6. Activated protein C protects from GvHD via PAR2/PAR3 signalling in regulatory T-cells.
Ranjan S; Goihl A; Kohli S; Gadi I; Pierau M; Shahzad K; Gupta D; Bock F; Wang H; Shaikh H; Kähne T; Reinhold D; Bank U; Zenclussen AC; Niemz J; Schnöder TM; Brunner-Weinzierl M; Fischer T; Kalinski T; Schraven B; Luft T; Huehn J; Naumann M; Heidel FH; Isermann B
Nat Commun; 2017 Aug; 8(1):311. PubMed ID: 28827518
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology of GvHD and Other HSCT-Related Major Complications.
Ghimire S; Weber D; Mavin E; Wang XN; Dickinson AM; Holler E
Front Immunol; 2017; 8():79. PubMed ID: 28373870
[TBL] [Abstract][Full Text] [Related]
8. Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease.
Pierini A; Colonna L; Alvarez M; Schneidawind D; Nishikii H; Baker J; Pan Y; Florek M; Kim BS; Negrin RS
J Immunol; 2015 Jul; 195(1):347-55. PubMed ID: 25994967
[TBL] [Abstract][Full Text] [Related]
9. Subconjunctivally applied naïve Tregs support corneal graft survival in baby rats.
Hildebrand A; Jarsch C; Kern Y; Böhringer D; Reinhard T; Schwartzkopff J
Mol Vis; 2014; 20():1749-57. PubMed ID: 25558177
[TBL] [Abstract][Full Text] [Related]
10. Minor antigen distribution predicts site-specific graft-versus-tumor activity of adoptively transferred, minor antigen-specific CD8 T Cells.
Shand JC; Qin H; Nasholm N; Capitini CM; Fry TJ
Biol Blood Marrow Transplant; 2014 Jan; 20(1):26-36. PubMed ID: 24141010
[TBL] [Abstract][Full Text] [Related]
11. The role of regulatory T cells in the biology of graft versus host disease.
Beres AJ; Drobyski WR
Front Immunol; 2013; 4():163. PubMed ID: 23805140
[TBL] [Abstract][Full Text] [Related]
12. Immune reconstitution and graft-versus-host reactions in rat models of allogeneic hematopoietic cell transplantation.
Zinöcker S; Dressel R; Wang XN; Dickinson AM; Rolstad B
Front Immunol; 2012; 3():355. PubMed ID: 23226148
[TBL] [Abstract][Full Text] [Related]
13. Chemokine receptor CXCR3 agonist prevents human T-cell migration in a humanized model of arthritic inflammation.
O'Boyle G; Fox CR; Walden HR; Willet JD; Mavin ER; Hine DW; Palmer JM; Barker CE; Lamb CA; Ali S; Kirby JA
Proc Natl Acad Sci U S A; 2012 Mar; 109(12):4598-603. PubMed ID: 22392992
[TBL] [Abstract][Full Text] [Related]
14. Role of immune-regulatory cells in skin pathology.
Ilkovitch D
J Leukoc Biol; 2011 Jan; 89(1):41-9. PubMed ID: 20628065
[TBL] [Abstract][Full Text] [Related]
15. Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during priming.
Wang XN; Haniffa MA; Holtick U; Collin MP; Jackson G; Hilkens CM; Holler E; Edinger M; Hoffmann P; Dickinson AM
Transplantation; 2009 Jul; 88(2):188-97. PubMed ID: 19623013
[TBL] [Abstract][Full Text] [Related]
16. Regulatory T cells inhibit CD8(+) T-cell tissue invasion in human skin graft-versus-host reactions.
Mavin E; Ahmed SS; O'Boyle G; Turner B; Douglass S; Norden J; Collin M; Ali S; Dickinson A; Wang XN
Transplantation; 2012 Sep; 94(5):456-64. PubMed ID: 22890131
[TBL] [Abstract][Full Text] [Related]
17. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
[TBL] [Abstract][Full Text] [Related]
18. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
Xia G; Truitt RL; Johnson BD
Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
[TBL] [Abstract][Full Text] [Related]
19. Modulation of graft-versus-host disease: role of regulatory T lymphocytes.
Hess AD
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):13-21. PubMed ID: 16399597
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
